Activism: latest news

Activism features

Activism in your own words

Activism news from aidsmap

  • European Cure Review concentrates on HIV therapeutic vaccines

    A cure for HIV would almost inevitably have to involve a vaccine to improve the body’s natural ability to control HIV, a seminar on European HIV cure research heard recently. The STEPS seminar, held by the European AIDS Treatment ...

    16 November 2017 | Gus Cairns
  • France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic

    France is launching a new study which will enrol 3000 new pre-exposure prophylaxis (PrEP) users over the next three years, Jean-Michel Molina told the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris this week. Whereas previous studies, ...

    28 July 2017 | Roger Pebody
  • Hope overshadowed – the US PrEP Summit

    The US National HIV PrEP Summit, which took place in early December in San Francisco, was one of the most extraordinary HIV meetings I have ever been to. This first-ever gathering of 600 people involved in ...

    31 January 2017 | Gus Cairns
  • Policy makers’ inaction is leading people to take PrEP ‘in the wild’

    An increasing number of gay men and others at risk of HIV are seeking to protect their health with PrEP (pre-exposure prophylaxis), but the lack of PrEP provision and lack of regulatory approval in many countries is leading ...

    19 October 2016 | Roger Pebody
  • Gains in curbing HIV epidemic could be lost without continued commitment, AIDS 2016 speakers say

    Participants at the 21st International AIDS Conference (AIDS 2016), taking place this week in Durban, South Africa, reviewed the remarkable gains that have been made in access to HIV treatment and new prevention tools since the conference was last held ...

    19 July 2016 | Liz Highleyman
  • People who inject drugs have other priorities ahead of PrEP

    People who inject drugs have fundamental concerns about HIV pre-exposure prophylaxis (PrEP) and the manner in which it is being promoted, according to a consultation conducted by the International Network of People who Use Drugs (INPUD). With limited availability ...

    17 June 2016 | Roger Pebody
  • England’s PrEP policy in disarray after NHS U-turn

    Activists, individuals at risk of HIV, and clinicians have reacted with anger to an official U-turn on provision of HIV pre-exposure prophylaxis (PrEP). NHS England officials have refused to allow a draft policy on PrEP to go forward for ...

    22 March 2016 | Roger Pebody
  • London sexual health clinics step up their support for people buying PrEP online

    Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring to PrEP users. This is in a context of increasing frustration with ...

    29 January 2016 | Roger Pebody
  • France approves PrEP

    In a historic move, France has become the first country outside the USA, and the first country with a centrally-organised, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it.The French Minister of Health, ...

    24 November 2015 | Gus Cairns
  • Harm reduction conference calls for political leadership to reform drugs policy

    The biggest challenges to harm reduction are drugs policy and drugs laws, the Malaysian harm reduction leader Dr Adeeba Kamarulzaman told the 24th International Harm Reduction Conference in Kuala Lumpur last week.Numerous speakers said that punitive and prohibitionist drugs policies have restricted ...

    27 October 2015 | Roger Pebody
More news

Activism news selected from other sources

  • Achieving HIV Targets through Human Rights Instruments

    This post presents an overview of the human rights political mechanisms and expert bodies available to activists at the Human Rights Council, as well as resources for how they can be utilized.

    20 November 2017 | MSMGF
  • Harm Reduction Beyond Numbers

    How cultural attitudes, the political environment, and donor expectations shape harm reduction – and how they can divert it from its original mission as a movement.

    20 November 2017 | Drug Reporter
  • This year's 30 charity leaders on social media: be bold to succeed

    This year’s top 30 charity leaders on social media have been named, together with the winners in each of the six award categories. The annual social CEOs awards aim to encourage even more leaders to excel online, and this year’s winners, announced on 16 November at an event hosted by JustGiving, demonstrate that those willing to take risks will gain traction – even without a large budget. The top 30 are not ranked, but the overall winner is Matthew Hodson, executive director of NAM.

    17 November 2017 | The Guardian
  • POZ Founder Sean Strub Wins Election for Mayor of Milford, Penn.

    Elsewhere, voters expand Medicaid and elect transgender women and a criminalization reformer.

    09 November 2017 | Poz
  • ‘BPM (Beats Per Minute)’ is the Sexiest Damn Film of 2017. Period.

    Director Robin Campillo never allows us to forget that the young men (and women!) who populate this activism group are every bit as interested in dancing and getting laid as in making a statement. And, come to think of it, his characters’ connection to their sexual humanity during a time when touching a person with HIV was abhorrent is a heady statement in and of itself.

    07 November 2017 | My Fabulous Disease
  • U=U taking off in 2017

    U=U is a simple but hugely important campaign based on a solid foundation of scientific evidence. The clarity of the message will make it easier to promote the undeniable benefits of treatment.

    02 November 2017 | The Lancet HIV
  • U=U Unites with ITPC to Improve the Lives of People Living with HIV

    The International Treatment Preparedness Coalition (ITPC) and Prevention Access Campaign (PAC) announced today a groundbreaking partnership that will amplify the Undetectable=Untransmittable (U=U) message among communities of people living with HIV worldwide.

    02 November 2017 | International Treatment Preparedness Coalition
  • Larry Kramer ‘Did Not Set Out to Be an Activist At All’

    Currently working on The American People: Volume 2, the founder of ACT UP and the Gay Men's Health Crisis talks about his legacy and Theatre Rhino's production of The Normal Heart.

    01 November 2017 | SF Weekly
  • Why AIDS Film “BPM” Has So Many Love Scenes—and So Much Dancing

    The film’s director and stars also discuss how ACT UP Paris differed from U.S. activism and what young viewers find exciting about “BPM.”

    30 October 2017 | Poz
  • Getting to GIPA 2.0: from Science to Activism

    Bruno Spire is a researcher living with HIV and a senior scientist at the French National Institute for Medical Research (INSERM). Bruno is a scientist, but more so, he is an advocate on HIV community-based research. In this personal narrative, Bruno shares his experience connecting science and activism and how to apply that concept to the GIPA ('Greater Involvement of People Living with HIV/AIDS') principles.

    19 October 2017 | IAS
More news


Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.